PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce the filing on SEDAR+ of its audited financial statements together with associated MD&A for the year ended ...

Vincerx common stock suspended by Nasdaq inadvertently; will resume trading at the open of business on April 21, 2025 Trading to be permanently suspended by Nasdaq at the open of business on April 23 ...

BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase: ...

To get it in your inbox, subscribe here. Inside an Indian pharmaceutical manufacturing plant. When they do, one of the biggest losers would likely be generic drug manufacturers. Since they account ...

President Donald Trump on Tuesday announced his next target for tariffs: the pharmaceutical industry. In remarks before the National Republican Congressional Committee, Trump said his administration ...

US drugmakers' shares drop 3% to 6% premarket European, Indian healthcare stocks drag down broader indexes Trump aims to shift pharma manufacturing to US, but analysts doubtful April 9 (Reuters ...

USA inflation reduction act. Credit: designer491 via Getty Images. Pharma companies will need to rethink business and research and development (R&D) strategies to mitigate against the global impact ...

The United States is India’s biggest market for pharmaceutical exports, which are its most successful industrial exports. By Alex Travelli Reporting from New Delhi An important segment of India ...

SAN MATEO, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has terminated the previously announced non-binding Letter of Intent (LOI) with Global ...

SAN MATEO, Calif. - Vincerx Pharma, Inc. (NASDAQ: VINC), currently valued at $2.77 million in market capitalization, announced today that it has ceased discussions for a potential merger with ...